Righini Matteo, Corsi Cristiana, Sciascia Nicola, Aiello Valeria, Ciurli Francesca, Lerario Sarah, Berti Gian Marco, Montanari Francesca, Conti Amalia, Cristalli Carlotta Pia, Menabò Soara, Caramanna Luca, Tondolo Francesco, Turchetti Daniela, La Manna Gaetano, Capelli Irene
Nephrology and Dialysis Unit, Santa Maria Delle Croci Hospital, Ravenna, Italy.
Department of Electrical, Electronic and Information Engineering "Guglielmo Marconi", University of Bologna, Bologna, Italy.
J Nephrol. 2025 Mar;38(2):621-631. doi: 10.1007/s40620-024-02181-6. Epub 2025 Feb 10.
Autosomal Dominant Polycystic Kidney Disease (ADPKD) is a monogenic disease having a prevalence of 1:400-1000 live births. Depending on kidney imaging, patients can be subdivided into Class 1 (typical) and Class 2 (atypical). The present study aims to provide better assessment of Class 2 patients to help define their family history, together with their clinical and radiological characteristics.
One hundred twenty-four PKD patients with abdominal Magnetic Resonance Imaging (MRI) for the staging of ADPKD, were retrospectively analyzed, aiming to focus on Class 2 ADPKD patients. Total kidney volume and total cyst volume were evaluated, while also assessing their clinical and genetic characteristics.
Twelve patients fulfilled the Mayo criteria for Class 2 ADPKD (two Class 2B and ten Class 2A). Extrarenal involvement was observed in 66.7% of cases, but only two subjects presented an estimated Glomerular Filtration Rate (eGFR) < 60 mL/min/1.73 m. A positive family history for cystic disease was more frequent compared to other published cohorts. Only 8.3% tested positive for a likely pathogenic mutation in the PKD1 gene. Class 2B patients showed a lower height-adjusted total kidney volume, with a lower percentage of total cyst volume.
Based on our results, atypical ADPKD does not represent an uncommon condition, being present in about 10% of MRI-evaluated patients diagnosed with ADPKD. Genetic tests are frequently negative for PKD1/PKD2, and total cyst volume and residual tissue volume do not increase the prognostic value of MRI in patients with these radiological characteristics. Other tools are needed to better characterize their kidney prognosis.
常染色体显性多囊肾病(ADPKD)是一种单基因疾病,在活产婴儿中的患病率为1:400 - 1000。根据肾脏成像结果,患者可分为1类(典型)和2类(非典型)。本研究旨在更好地评估2类患者,以帮助确定他们的家族史以及临床和放射学特征。
对124例因ADPKD分期而接受腹部磁共振成像(MRI)检查的PKD患者进行回顾性分析,重点关注2类ADPKD患者。评估了总肾体积和总囊肿体积,同时也评估了他们的临床和遗传特征。
12例患者符合2类ADPKD的梅奥标准(2例2B类和10例2A类)。66.7%的病例观察到肾外受累,但只有2例患者的估计肾小球滤过率(eGFR)<60 mL/min/1.73m²。与其他已发表的队列相比,囊性疾病的阳性家族史更为常见。只有8.3%的患者在PKD1基因中检测到可能的致病突变呈阳性。2B类患者的身高校正后总肾体积较低,总囊肿体积百分比也较低。
根据我们的结果,非典型ADPKD并非罕见情况,在接受MRI评估诊断为ADPKD的患者中约占10%。PKD1/PKD2基因检测通常为阴性,总囊肿体积和残余组织体积并未增加具有这些放射学特征患者的MRI预后价值。需要其他工具来更好地描述他们的肾脏预后情况。